{"name":"Quaker BioVentures","permalink":"quaker-bioventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/quaker-bioventures","homepage_url":"http://www.quakerbio.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"215-988-6800","description":"","email_address":"info@quakerbio.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jun 17 18:44:11 UTC 2009","updated_at":"Wed Jun 17 22:45:55 UTC 2009","overview":"<p>Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage start-ups to public companies. Founded in 2003, the firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007. Quaker BioVentures manages over $700 million in committed capital.</p>","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"Cira Centre 2929 Arch Street","address2":"","zip_code":"19104-2868","city":"Philadelphia","state_code":"PA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Partnet","person":{"first_name":"Brenda","last_name":"D. Gavin","permalink":"brenda-d-gavin","image":{"available_sizes":[[[107,150],"assets/images/resized/0004/9250/49250v1-max-150x150.jpg"],[[157,219],"assets/images/resized/0004/9250/49250v1-max-250x250.jpg"],[[157,219],"assets/images/resized/0004/9250/49250v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Richard","last_name":"S. Kollender","permalink":"richard-s-kollender","image":{"available_sizes":[[[107,150],"assets/images/resized/0004/9253/49253v1-max-150x150.jpg"],[[157,219],"assets/images/resized/0004/9253/49253v1-max-250x250.jpg"],[[157,219],"assets/images/resized/0004/9253/49253v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/cempra-pharmaceuticals-inc-series-c-46m/","source_description":"Cempra Pharmaceuticals, Inc.: Series C $46M","raised_amount":46000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":2,"company":{"name":"Cempra ","permalink":"cempra","image":{"available_sizes":[[[150,29],"assets/images/resized/0004/9163/49163v1-max-150x150.png"],[[250,49],"assets/images/resized/0004/9163/49163v1-max-250x250.png"],[[261,52],"assets/images/resized/0004/9163/49163v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"angel","source_url":"http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_23/ai_n30930200/?tag=content;col1","source_description":"Arginetix, Inc. Completes $2.3 Million Initial Financing and Technology License","raised_amount":2300000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":23,"company":{"name":"Arginetix","permalink":"arginetx","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9307/49307v1-max-150x150.png"],[[250,67],"assets/images/resized/0004/9307/49307v1-max-250x250.png"],[[450,122],"assets/images/resized/0004/9307/49307v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.mitsuiventures.com/en/investment/news/2008/20081006.html","source_description":"Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of LocteronÂ® in Hepatitis C","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":6,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/rapid-micro-biosystems-inc-series-a-186m/","source_description":"Rapid Micro Biosystems, Inc.: Series A $18.6M","raised_amount":18600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":6,"company":{"name":"Rapid Micro Biosystems","permalink":"rapid-micro-biosystems","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/6036/56036v1-max-150x150.png"],[[171,48],"assets/images/resized/0005/6036/56036v1-max-250x250.png"],[[171,48],"assets/images/resized/0005/6036/56036v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/neuronetics-inc-series-d-30m/","source_description":"Neuronetics, Inc.: Series D $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":27,"company":{"name":"Neuronetics","permalink":"neuronetics","image":{"available_sizes":[[[150,24],"assets/images/resized/0006/3974/63974v1-max-150x150.jpg"],[[250,40],"assets/images/resized/0006/3974/63974v1-max-250x250.jpg"],[[286,46],"assets/images/resized/0006/3974/63974v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://onbiovc.com/sleep-solutions-inc-series-f-20m/","source_description":"Sleep Solutions, Inc.: Series F $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":30,"company":{"name":"Sleep Solutions","permalink":"sleep-solutions","image":{"available_sizes":[[[150,26],"assets/images/resized/0006/4298/64298v1-max-150x150.jpg"],[[250,44],"assets/images/resized/0006/4298/64298v1-max-250x250.jpg"],[[342,61],"assets/images/resized/0006/4298/64298v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/arginetix-inc-series-b-46m/","source_description":"Arginetix, Inc.: Series B $4.6M","raised_amount":4600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":2,"company":{"name":"Arginetix","permalink":"arginetx","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9307/49307v1-max-150x150.png"],[[250,67],"assets/images/resized/0004/9307/49307v1-max-250x250.png"],[[450,122],"assets/images/resized/0004/9307/49307v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020091217e5ch000jh&r=Rss&s=DJFVW","source_description":"Regado Biosciences Stays Patient, Looks To Europe With New $40M  ","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":17,"company":{"name":"Regado Biosciences","permalink":"regado-biosciences","image":{"available_sizes":[[[150,23],"assets/images/resized/0007/0256/70256v1-max-150x150.jpg"],[[250,39],"assets/images/resized/0007/0256/70256v1-max-250x250.jpg"],[[352,56],"assets/images/resized/0007/0256/70256v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://eon.businesswire.com/portal/site/eon/permalink/?ndmViewId=news_view&newsId=20100112005476&newsLang=en","source_description":"BioLeap, Inc. Secures $5M Series A Financing from Adams Capital Management and Quaker BioVentures","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":12,"company":{"name":"BioLeap","permalink":"bioleap","image":{"available_sizes":[[[150,48],"assets/images/resized/0007/3096/73096v1-max-150x150.jpg"],[[178,58],"assets/images/resized/0007/3096/73096v1-max-250x250.jpg"],[[178,58],"assets/images/resized/0007/3096/73096v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/tarsa-therapeutics-inc-series-a-24m/","source_description":"Tarsa Therapeutics, Inc.: Series A $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":17,"company":{"name":"Tarsa Therapeutics","permalink":"tarsa-therapeutics","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4051/74051v1-max-150x150.jpg"],[[250,134],"assets/images/resized/0007/4051/74051v1-max-250x250.jpg"],[[345,186],"assets/images/resized/0007/4051/74051v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/transenterix-inc-series-b-55m/","source_description":"TransEnterix, Inc.: Series B $55M","raised_amount":55000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":21,"company":{"name":"TransEnterix","permalink":"transenterix","image":{"available_sizes":[[[150,32],"assets/images/resized/0007/4457/74457v1-max-150x150.jpg"],[[185,40],"assets/images/resized/0007/4457/74457v1-max-250x250.jpg"],[[185,40],"assets/images/resized/0007/4457/74457v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.tengion.com/news/press/20071015.cfm","source_description":"Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":15,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://biolex.com/pdfs/Biolex%20-%20Series%20C%20Press%20Release%20-%20May%2024,%202007.pdf","source_description":"BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":24,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://salesandmarketingnetwork.com/news_release.php?ID=2019125","source_description":"Argolyn Bioscience Raises $15.8 Million Round of Financing","raised_amount":15800000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":25,"company":{"name":"Argolyn Bioscience","permalink":"argolyn-bioscience","image":{"available_sizes":[[[150,23],"assets/images/resized/0008/0194/80194v1-max-150x150.jpg"],[[250,38],"assets/images/resized/0008/0194/80194v1-max-250x250.jpg"],[[297,46],"assets/images/resized/0008/0194/80194v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.allbusiness.com/services/business-services/4335584-1.html","source_description":"StageMark Completes $1.6 Million Venture Capital Financing.","raised_amount":1600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":23,"company":{"name":"StageMark","permalink":"stagemark","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.tengion.com/news/press/20060623.cfm","source_description":"Tengion Inc. Completes $50 Million Series \"B\" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":23,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.nitricbio.com/aboutus.html","source_description":"Nitric Bio received its initial funding and has raised a total of $14M","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":31,"company":{"name":"Nitric Bio","permalink":"nitric-bio","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/4658/84658v1-max-150x150.jpg"],[[250,66],"assets/images/resized/0008/4658/84658v1-max-250x250.jpg"],[[250,66],"assets/images/resized/0008/4658/84658v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/tearscience-inc-series-c-445m/","source_description":"TearScience, Inc.: Series C $44.5M","raised_amount":44500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":6,"company":{"name":"TearScience","permalink":"tearscience","image":{"available_sizes":[[[150,9],"assets/images/resized/0008/6329/86329v1-max-150x150.png"],[[250,16],"assets/images/resized/0008/6329/86329v1-max-250x250.png"],[[450,29],"assets/images/resized/0008/6329/86329v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://biolex.com/pdfs/Biolex%20Raises%20$36M.pdf","source_description":"BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING","raised_amount":36000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":9,"funded_day":1,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://finance.yahoo.com/news/Arginetix-and-Immune-Control-bw-1922954142.html?x=0&.v=1","source_description":"Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Corridor Pharmaceuticals","permalink":"corridor-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetralogic-nabs-32m-round-lead-cancer-therapy/2010-08-10?utm_medium=rss&utm_source=rss","source_description":"TetraLogic nabs $32M round for lead cancer therapy  Read more: TetraLogic nabs $32M round for lead cancer therapy","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.celatorpharma.com/new/pr_20100901.html","source_description":"CELATORÂ® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":1,"company":{"name":"Celator Pharmaceuticals","permalink":"celator-pharmaceuticals","image":{"available_sizes":[[[150,44],"assets/images/resized/0010/0352/100352v1-max-150x150.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-250x250.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.achillion.com/releasedetail.cfm?ReleaseID=500371","source_description":"Achillion Announces Private Placement of $50 Million","raised_amount":50100000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":18,"company":{"name":"Achillion Pharmaceuticals","permalink":"achillion-pharmaceuticals","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/0871/60871v2-max-150x150.png"],[[250,56],"assets/images/resized/0006/0871/60871v2-max-250x250.png"],[[303,69],"assets/images/resized/0006/0871/60871v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/01/raindance-technologies-closes-375m.html","source_description":"RainDance Technologies Closes $37.5M Series D Financing Round","raised_amount":37500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":25,"company":{"name":"RainDance Technologies","permalink":"raindance-technologies","image":{"available_sizes":[[[150,50],"assets/images/resized/0011/9034/119034v1-max-150x150.png"],[[222,74],"assets/images/resized/0011/9034/119034v1-max-250x250.png"],[[222,74],"assets/images/resized/0011/9034/119034v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.marketwire.com/press-release/neuronetics-inc-raises-30-million-in-series-e-financing-1514679.htm","source_description":"Neuronetics, Inc. Raises $30 Million in Series E Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":16,"company":{"name":"Neuronetics","permalink":"neuronetics","image":{"available_sizes":[[[150,24],"assets/images/resized/0006/3974/63974v1-max-150x150.jpg"],[[250,40],"assets/images/resized/0006/3974/63974v1-max-250x250.jpg"],[[286,46],"assets/images/resized/0006/3974/63974v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.novasom.com/press_room/financing_6-27-2011.pdf","source_description":"NovaSom Closes $35 Million in Equity Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":27,"company":{"name":"NovaSom","permalink":"novasom","image":{"available_sizes":[[[150,38],"assets/images/resized/0014/1362/141362v1-max-150x150.png"],[[250,64],"assets/images/resized/0014/1362/141362v1-max-250x250.png"],[[287,74],"assets/images/resized/0014/1362/141362v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.prnewswire.com/news-releases/tarsa-therapeutics-completes-28-million-series-b-financing-to-advance-ostora-oral-calcitonin-142908965.html","source_description":"Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":16,"company":{"name":"Tarsa Therapeutics","permalink":"tarsa-therapeutics","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4051/74051v1-max-150x150.jpg"],[[250,134],"assets/images/resized/0007/4051/74051v1-max-250x250.jpg"],[[345,186],"assets/images/resized/0007/4051/74051v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.intactvascular.com/news/20120905.php","source_description":" Intact Vascular Announces $15.5 MM Series A Financing and Names Dennis Wahr, M.D. as Chairman","raised_amount":15500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":5,"company":{"name":"Intact Vascular","permalink":"intact-vascular","image":{"available_sizes":[[[150,64],"assets/images/resized/0020/9977/209977v1-max-150x150.jpg"],[[206,88],"assets/images/resized/0020/9977/209977v1-max-250x250.jpg"],[[206,88],"assets/images/resized/0020/9977/209977v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}